Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study. (Q46009745)
Jump to navigation
Jump to search
scientific article published in April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study. |
scientific article published in April 2009 |
Statements
1 reference
Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study. (English)
1 reference
Ronald Emkey
1 reference
Pierre D Delmas
1 reference
Michael Bolognese
1 reference
Joao Lindolfo C Borges
1 reference
Felicia Cosman
1 reference
Sergio Ragi-Eis
1 reference
Christopher Recknor
1 reference
Cristiano A Zerbini
1 reference
Colin Neate
1 reference
Farhad Sedarati
1 reference
Solomon Epstein
1 reference
1 April 2009
1 reference
1 reference
31
1 reference
4
1 reference
751-761
1 reference